Annual Working Capital
$986.15 M
-$22.24 M-2.21%
December 31, 2023
Summary
- As of February 7, 2025, DNLI annual working capital is $986.15 million, with the most recent change of -$22.24 million (-2.21%) on December 31, 2023.
- During the last 3 years, DNLI annual working capital has fallen by -$437.80 million (-30.75%).
- DNLI annual working capital is now -30.75% below its all-time high of $1.42 billion, reached on December 31, 2020.
Performance
DNLI Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$781.75 M
-$72.10 M-8.44%
September 30, 2024
Summary
- As of February 7, 2025, DNLI quarterly working capital is $781.75 million, with the most recent change of -$72.10 million (-8.44%) on September 30, 2024.
- Over the past year, DNLI quarterly working capital has dropped by -$72.10 million (-8.44%).
- DNLI quarterly working capital is now -45.10% below its all-time high of $1.42 billion, reached on December 31, 2020.
Performance
DNLI Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
DNLI Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.2% | -8.4% |
| 3 y3 years | -30.8% | -22.5% |
| 5 y5 years | +120.1% | -22.5% |
DNLI Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.2% | +90.0% | -32.3% | +50.6% |
| 5 y | 5-year | -30.8% | +156.3% | -45.1% | +103.2% |
| alltime | all time | -30.8% | +3192.7% | -45.1% | +352.3% |
Denali Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $781.75 M(-8.4%) |
| Jun 2024 | - | $853.85 M(-4.2%) |
| Mar 2024 | - | $890.99 M(-9.6%) |
| Dec 2023 | $986.15 M(-2.2%) | $986.15 M(-8.0%) |
| Sep 2023 | - | $1.07 B(-7.2%) |
| Jun 2023 | - | $1.15 B(+23.6%) |
| Mar 2023 | - | $934.08 M(-7.4%) |
| Dec 2022 | $1.01 B(+94.3%) | $1.01 B(+29.6%) |
| Sep 2022 | - | $777.86 M(+1.5%) |
| Jun 2022 | - | $766.44 M(+18.4%) |
| Mar 2022 | - | $647.20 M(+24.7%) |
| Dec 2021 | $518.99 M(-63.6%) | $518.99 M(-48.2%) |
| Sep 2021 | - | $1.00 B(-22.4%) |
| Jun 2021 | - | $1.29 B(-6.3%) |
| Mar 2021 | - | $1.38 B(-3.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $1.42 B(+270.2%) | $1.42 B(+64.5%) |
| Sep 2020 | - | $865.45 M(+72.8%) |
| Jun 2020 | - | $500.94 M(-10.1%) |
| Mar 2020 | - | $557.15 M(+44.8%) |
| Dec 2019 | $384.69 M(-14.1%) | $384.69 M(-14.1%) |
| Sep 2019 | - | $447.69 M(-0.4%) |
| Jun 2019 | - | $449.43 M(-1.5%) |
| Mar 2019 | - | $456.29 M(+1.8%) |
| Dec 2018 | $448.05 M(+13.3%) | $448.05 M(+27.4%) |
| Sep 2018 | - | $351.79 M(+1.6%) |
| Jun 2018 | - | $346.41 M(-3.8%) |
| Mar 2018 | - | $360.25 M(-8.9%) |
| Dec 2017 | $395.44 M(+128.8%) | $395.44 M(+122.0%) |
| Sep 2017 | - | $178.09 M(+3.0%) |
| Dec 2016 | $172.85 M(+477.1%) | $172.85 M |
| Dec 2015 | $29.95 M | - |
FAQ
- What is Denali Therapeutics annual working capital?
- What is the all time high annual working capital for Denali Therapeutics?
- What is Denali Therapeutics annual working capital year-on-year change?
- What is Denali Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Denali Therapeutics?
- What is Denali Therapeutics quarterly working capital year-on-year change?
What is Denali Therapeutics annual working capital?
The current annual working capital of DNLI is $986.15 M
What is the all time high annual working capital for Denali Therapeutics?
Denali Therapeutics all-time high annual working capital is $1.42 B
What is Denali Therapeutics annual working capital year-on-year change?
Over the past year, DNLI annual working capital has changed by -$22.24 M (-2.21%)
What is Denali Therapeutics quarterly working capital?
The current quarterly working capital of DNLI is $781.75 M
What is the all time high quarterly working capital for Denali Therapeutics?
Denali Therapeutics all-time high quarterly working capital is $1.42 B
What is Denali Therapeutics quarterly working capital year-on-year change?
Over the past year, DNLI quarterly working capital has changed by -$72.10 M (-8.44%)